Correlation Between Medigen Biotechnology and Insyde Software

Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and Insyde Software at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and Insyde Software into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medigen Biotechnology and Insyde Software, you can compare the effects of market volatilities on Medigen Biotechnology and Insyde Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of Insyde Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and Insyde Software.

Diversification Opportunities for Medigen Biotechnology and Insyde Software

-0.22

Correlation Coefficient

Medigen Biotechnology  Insyde Software

Very good diversification

The 3 months correlation between Medigen and Insyde is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and Insyde Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insyde Software and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with Insyde Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insyde Software has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and Insyde Software go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and Insyde Software

Assuming the 90 days trading horizon Medigen Biotechnology is expected to generate 0.63 times more return on investment than Insyde Software. However, Medigen Biotechnology is 1.58 times less risky than Insyde Software. It trades about 0.04 of its potential returns per unit of risk. Insyde Software is currently generating about -0.11 per unit of risk. If you would invest  3,240  in Medigen Biotechnology on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Medigen Biotechnology or generate 3.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Medigen Biotechnology  vs.  Insyde Software

Medigen Biotechnology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Medigen Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Insyde Software

Risk-Adjusted Performance

Very Weak

Over the last 90 days Insyde Software has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Medigen Biotechnology and Insyde Software

The main advantage of trading using opposite Medigen Biotechnology and Insyde Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, Insyde Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insyde Software will offset losses from the drop in Insyde Software's long position.

The idea behind Medigen Biotechnology and Insyde Software pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..